Glucocorticoids Bind to SARS-CoV-2 S1 at Multiple Sites Causing Cooperative Inhibition of SARS-CoV-2 S1 Interaction With ACE2

Article

Abstract: Dexamethasone may reduce mortality in COVID-19 patients. Whether dexamethasone or endogenous glucoco

Palabras claves:

ACE2 (angiotensin converting enzyme 2), CORONAVIRUS, covid, glucocorticoids, innate immunity, SARS-COV-2

Autores:

Elahi S., Eugenio Hardy, Fernandez‐Patron C., Glover J.N.M., Panigrahi R., Sarker H.

Fuentes:

scopus